Feb 20, 2025

I recently came across news about significant investments in renewable energy insurance by MSIG Asia and RiskPoint, in anticipation of a potential $3 trillion investment in power generation in the Asia-Pacific region by 2033. Additionally, global insurtech funding hit a seven-year low in 2024, with Australia experiencing a notable decrease in share. On a different note, ongoing research and development activities are expected to drive the global dermatology market to reach $32.98 billion by 2029.

In other news, financial expert Charles Lemonides, founder of ValueWorks, cautioned that the market is approaching the last stage of the bull cycle. Lemonides emphasized the importance of investing in stocks with growth potential, such as Rivian, to navigate the upcoming speculative market top. He highlighted the need to own diverse stocks with real-world assets worth more than their current value to weather the challenging market environment ahead.

Furthermore, Axios Pro Rata reported on the departures from Intel Capital’s investor team in the year leading up to the announcement of its spinout plans, amidst recent corporate-level turbulence and challenges in the AI sector. Conflicting reports on the Trump administration’s stance on a foreign firm acquiring a stake in Intel were also mentioned, with potential implications for the global regulatory landscape.

Notable venture capital deals have been making headlines, including Thinking Machines’ $1 billion funding round, Saronic’s $600 million valuation, and Verkada’s $200 million Series E funding. These investments reflect the ongoing interest and support for innovative companies in various sectors, ranging from AI and drone technology to low-carbon building materials and medical imaging.

Lastly, I learned about significant funding rounds in the healthcare and technology sectors, with companies like Avandra, Subsense, and ClustroAI securing millions in funding to support their growth. These funding rounds highlight the continued interest and investment in innovative companies across various industries, showcasing a diverse range of companies securing significant investments to further their development.

Stay Well!